Astrana Health (NASDAQ:ASTH) reported quarterly earnings of $0.01 per share which missed the analyst consensus estimate of $0.41 by 97.54 percent. This is a 96.97 percent decrease over earnings of $0.33 per share from the same period last year. The company reported quarterly sales of $956.048 million which beat the analyst consensus estimate of $952.789 million by 0.34 percent. This is a 99.71 percent increase over sales of $478.710 million the same period last year.